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Summary
The maintenance of energetic homeostasis in the face of
limited available nutrients is a complex problem faced by all
organisms. One important mechanism to maintain energetic
homeostasis involves the activation of the energy sensor
AMP-activated protein kinase (AMPK). AMPK is a cell-
autonomous energy sensor that is highly sensitive to and
regulated by the ATP to ADP and ATP to AMP ratios.
However, the genetic analysis of AMPK signaling in
vertebrates has been complicated by the existence of
multiple redundant AMPK subunits. Here, we describe the
identification of mutations in the single Drosophila
melanogaster AMPK catalytic subunit (AMPKa) and their
implications for neural maintenance and integrity. This
article provides a citation replacement for previously
published ampka alleles, transgenes and neuronal
phenotypes, which remain accurate; however, they were
used in a previously published study that has subsequently
been retracted (Mirouse et al., 2013).
 2013. Published by The Company of Biologists Ltd. This is an
Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/
licenses/by/3.0), which permits unrestricted use, distribution
and reproduction in any medium provided that the original
work is properly attributed.
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Introduction
AMP-activated protein kinase (AMPK) acts as a cellular energy
sensor and is activated by ADP and AMP, which accumulate
when ATP levels are low (Braco et al., 2012; Johnson et al.,
2010; Kahn et al., 2005). AMPK then mediates the cellular
response to energetic stress by activating energy-producing
activities, while inhibiting energy-consuming ones, such as
protein translation and cell growth/division. AMPK is a
heterotrimeric protein with a 63-kDa catalytic a subunit and
two regulatory b and c subunits (38 and 36 kDa, respectively),
each of which is encoded by distinct genes (a1, a2; b1, b2; c1,
c2, c3 in mammals; Davies et al., 1994; Gao et al., 1996;
Mitchelhill et al., 1994; Nielsen et al., 2003; Stapleton et al.,
1996). AMPK is also implicated in a number of signaling
pathways (Hardie, 2004; Hardie, 2007; Shaw, 2009).
AMPK can be activated upstream by the tumor suppressor
liver kinase B1 (LKB1; Amin et al., 2009; Shaw et al., 2004) and
Ca2+/calmodulin-dependent kinase kinase b (Hawley et al., 2005;
Hurley et al., 2005). AMPK signaling acts downstream to inhibit
protein and lipid synthesis, for example, activating elongation
factor-2 kinase, which causes inhibition of the elongation step of
translation (Horman et al., 2002; Winder et al., 1997); inhibiting
the target-of-rapamycin (TOR) pathway, which stimulates the
initiation step of protein synthesis by the phosphorylation of
multiple targets (Proud, 2004); and phosphorylating and
inhibiting the fatty acid synthesis and rate-limiting enzyme
ACC, which subsequently lowers malonyl-CoA levels and
increases fatty acid uptake into mitochondria (Hardie and
Hawley, 2001; Merrill et al., 1997; Winder et al., 1997).
We have further investigated the role of AMPK in vivo and
show here that AMPK is required to maintain cellular integrity in
neurons within Drosophila melanogaster.
Results and Discussion
AMPK contains three protein subunits, a, b, and c, which form a
heterotrimer. The a subunit (AMPKa) encodes for a highly
conserved serine/threonine kinase, whereas the other subunits are
regulatory. From a Drosophila melanogaster forward genetic
screen for mutants affecting larval neuronal dendrite
development and maintenance (Medina et al., 2006), we
identified several lethal mutations in AMPKa. The ethyl
methane sulfonate (EMS) mutants, ampka1 and ampka2, contain
a single amino acid change (S211L, completely conserved) and a
premature stop codon (Q295 STOP), respectively, whereas
ampka3 has a 16-bp deletion creating a stop codon (Y141
STOP; Fig. 1A). All ampka mutants, whether homozygous or in
trans with a deletion covering the locus, displayed a completely
penetrant and nearly identical phenotype, with significantly
enlarged plasma membrane domains in dendrites, but not in
axonal compartments (Fig. 1C; unpublished data). In addition,
ampka1 and ampka3 could be rescued to viability with either a











wild-type AMPKa transgene, or a transgene that is tagged with
the red fluorescent protein mCherry (Fig. 1D; see Materials and
Methods). The requirement for ampka is cell autonomous
because transgene expression within only neurons rescues the
phenotype (Fig. 1D). Therefore, these mutations represent
genetic disruptions of the single AMPKa catalytic subunit in
the D. melanogaster genome. (These data and these alleles were
previously published as a part of a retracted study (Mirouse et al.,
2013) but accurately allow the genetic analysis of AMPK
function in vivo.)
The recovery of null mutations in ampka has allowed for in
vivo analysis of AMPK function in a multicellular organism,
which has revealed an unexpected role for the kinase in the
maintenance of cell integrity. This implies that at least one of
the pathways that normally maintain cell integrity cannot
function without AMPK activity. These results are in
agreement with previous studies that have investigated the role
of both AMPKb and AMPKc in neural maintenance and
neurodegeneration in Drosophila, and found that both of these
AMPK regulatory subunits are also essential to the maintenance
of neural integrity (Andersen et al., 2012; Spasić et al., 2008;
Tschäpe et al., 2002).
Materials and Methods
Mutant AMPKa allele isolation and characterization
An ethyl methane sulfonate mutagenesis screen on the X chromosome was
performed as previously described (Medina et al., 2006). Early second instar
larvae were visually screened for dendritic defects using fluorescent microscopy.
The ampka mutants, lethal at late second/third instar stages, were mapped to
,150 kb on the X chromosome using a molecularly defined deficiency
(Df[1]Exel6227), an undefined deficiency (Df[1]AD11), and a duplication of
the Y chromosome (Dp[1;Y]/Df[1]svr). Predicted coding regions for genes in the
region were sequenced using PCR amplicons made from mutant genomic DNA,
and one gene (AMPKa; CG3051; NM_057965) was discovered that had
significant mutations in all three alleles. Alleles have been contributed to the
Bloomington Stock Center.
Construction of AMPKa transgenes
The wild-type AMPKa transgene was cloned into the pUAST vector (Brand and
Perrimon, 1993) as an EcoRI–BglII fragment of an EST, corresponding to an
AMPKa-RA transcript (http://flybase.org). The mCherry-AMPKa fusion protein
was made using a mCherry construct (provided by R. Tsien, University of
California, San Diego, San Diego, CA) at the N terminus fused in-frame to AMPKa
into the pUAST vector. The UAS-mCherry-AMPKa transgene rescues viability
and fertility when expressed by Ubiquitin-Gal4 in either ampka1 or ampka3
mutants. The phosphomimetic-activated form of AMPKa (AMPKa T184D) was
made by PCR-based, site-directed mutagenesis converting base C549 to G549.
The transgenes were introduced into a w1118 stock by P element-mediated
transformation. Transgenes have been contributed to the Bloomington Stock
Center.
Neuron visualization technique
Larvae were covered in a glycerol solution at 22 C̊ and gently covered with a
coverslip (22650 mm; Fisher Scientific) to restrict movement, but not cause
bursting of the body wall. Images were quickly taken using a Pan-Neofluar 406/
1.3 NA oil immersion lens with a 2-mm optical slice and LSM Imaging software
(Carl Zeiss MicroImaging, Inc.). Images were resized and cropped with Photoshop
(Adobe), and imported into Illustrator (Adobe) for labels and arrangement.
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